Faes Farma, S.A
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Colme to treat chronic alcoholism; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. In addition, it offers sitagliptine, and sitagliptine and metformine products to treat diabetes type-II; Hidroferol; Acoxxel; Pankreoflat, an OTC products; Hemorrance for the treatment of haemorrhoids; and respiratory products, as well as ProFaes4 Adultos, Digest, Viajeros, Edad Escolar, and Dual Vit. Further, the company provides Diosmin and Micronized Diosmin for chronic venous insufficiency; Sulbutiamine to treat asthenia, concentration, and memory deficit; Arginine Aspartate for the treatment of erectile dysfunction; swine feeding and nutrition products; and products and services for the animal nutrition industry. It operates in approximately 60 countries in Latin America, Africa, the Middle East, Asia, and Europe. Faes Farma, S.A. was founded in 1933 and is headquartered in Madrid, Spain. Show More...
-
Website http://faesfarma.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 3.32 EUR
-
Last Updated 25-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 0.1 0.07 0.08 0.1 0.1 0.12 0.14 0.16 0.2 0.23 0.25 Dividends EUR 0.09 0.06 0.04 0.06 0.1 0.09 0.11 0.11 0.11 0.16 0.16 Payout Ratio % * 89.2 96.9 41.5 47.0 74.1 72.9 65.3 69.5 52.4 60.9 66.0 Shares Mil 203.0 203.0 218.0 233.0 245.0 252.0 252.0 258.0 266.0 273.0 281.0 Book Value Per Share * EUR 0.68 0.74 0.91 0.91 0.94 0.98 1.07 1.17 1.29 1.43 1.47 Free Cash Flow Per Share * EUR 0.04 0.03 0.1 0.13 0.06 0.14 0.12 0.12 0.15 0.22 Return on Assets % 7.5 4.82 6.75 7.9 9.17 10.88 11.77 11.09 11.33 13.13 Financial Leverage (Average) 1.8 1.74 1.55 1.44 1.17 1.14 1.16 1.34 1.34 1.2 1.2 Return on Equity % 13.87 8.51 11.08 11.82 11.88 12.57 13.57 13.95 15.17 16.55 Return on Invested Capital % 10.02 5.83 8.67 9.93 10.85 12.34 13.49 12.88 13.22 15.22 Interest Coverage 6.08 9.45 15.46 38.47 503.94 240.47 242.14 157.28 Current Ratio 1.08 1.12 1.57 1.66 2.95 3.65 4.05 3.01 2.1 3.09 3.09 Quick Ratio 0.49 0.67 0.98 1.05 1.84 2.55 3.03 2.12 1.52 2.09 2.09 Debt/Equity 0.19 0.19 0.18 0.1 0.02 0.13 0.010 0.010